Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_32643 | 14 | 0.28 | Mlig455_043702 | Neo: - Age: - |
Mlig455_043702 {REF} {Length: 970} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=64.7, Expect=1e-12]} {RNA1509_35604} {RNA1310_57814} {RNA815_29718} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.296 | 0.698 | 0.99977 | 1.00000 | |
RegionR2 | 2.143 | 0.698 | 0.94117 | 1.00000 | |
RegionR3 | -0.713 | 0.698 | 0.99983 | 1.00000 | |
RegionR4 | 0.124 | 0.698 | 0.99981 | 1.00000 | |
RegionR5 | 0.814 | 0.698 | 0.44487 | 0.80631 | |
RegionR6 | -0.808 | 0.698 | 0.99980 | 1.00000 | |
RegionR7 | -0.783 | 0.698 | 0.99977 | 1.00000 | |
RegionR8 | -0.48 | 0.698 | 0.99978 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.726 | 0.698 | 1.00000 | 1.00000 | |
RegenerationR2 | 1.548 | 0.698 | 0.48953 | 0.86753 | |
RegenerationR3 | -0.817 | 0.698 | 0.99987 | 1.00000 | |
RegenerationR4 | 0.094 | 0.698 | 0.88796 | 1.00000 | |
RegenerationR5 | -0.101 | 0.698 | 0.63888 | 0.92641 | |
RegenerationR6 | -0.651 | 0.698 | 0.99993 | 1.00000 | |
RegenerationBL | -0.64 | 0.698 | 0.99990 | 1.00000 | |
RegenerationTP | -0.583 | 0.698 | 1.00000 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_32643 | 14 | 0.28 | Mlig455_043702 | Neo: - Age: - |
3 | - | - | 1.000 | - | 1.000 | 1.000 | Mlig455_043702 {REF} {Length: 970} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=64.7, Expect=1e-12]} {RNA1509_35604} {RNA1310_57814} {RNA815_29718} | |
2. | MligTC455_32642 | 14 | 0.28 | Mlig455_026288 | Neo: - Age: - |
2.995 | - | - | 0.995 | - | 1.000 | 1.000 | Mlig455_026288 {REF} {Length: 962} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=52.4, Expect=4e-09]} {RNA1509_35604} {RNA1310_57814} {RNA815_29718} | |
3. | MligTC455_34498 | 36 | 0.75 | Mlig455_029862 | Neo: - Age: - |
NPLOC4 | 2.934 | - | - | 0.975 | - | 0.964 | 0.995 | Mlig455_029862 {REF} {Length: 1491} {TRANSSPLICED} {Pfam: NPL4 family, putative zinc binding region [PF05020.17, score=77.9]} {Human: ENSG00000182446, NPLOC4, NPL4 homolog, ubiquitin recognition factor, [Score=98.2, Expect=1e-21]} {Mouse: ENSMUSG00000039703, Nploc4, NPL4 homolog, ubiquitin recognition factor, [Score=102, Expect=3e-23]} {Celegans: WBGene00019121, npl-4.2, NPL (Yeast Nuclear Protein Localization) homolog, [Score=54.3, Expect=6e-08]} {Smed: dd_Smed_v6_5277_0_1, dd_Smed_v6_5277_0_1, [Score=102, Expect=1e-23]} {RNA1509_6797} {RNA1310_13992} {RNA815_5567} |
4. | MligTC455_34499 | 65 | 1.36 | Mlig455_025160, Mlig455_063937 | Neo: - Age: - |
2.929 | - | - | 0.973 | - | 0.960 | 0.996 | Mlig455_025160 {REF} {Length: 942} {RNA1310_54940} {RNA815_33690.1} Mlig455_063937 {REF} {Length: 995} {RNA1310_54940} {RNA815_33690.1} |
|
5. | MligTC455_15948 | 25 | 0.51 | Mlig455_007630 | Neo: - Age: - |
2.922 | - | - | 0.968 | - | 0.957 | 0.997 | Mlig455_007630 {REF} {Length: 1759} {Pfam: WSC domain [PF01822.21, score=54.5]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.4, Expect=2e-07]} {RNA1509_57286} {RNA1310_33352.2} {RNA815_14158.1} | |
6. | MligTC455_45032 | 56 | 1.16 | Mlig455_034186 | Neo: - Age: - |
KREMEN1 | 2.921 | - | - | 0.991 | - | 0.933 | 0.997 | Mlig455_034186 {REF} {Length: 1010} {Pfam: WSC domain [PF01822.21, score=53.3]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=51.2, Expect=3e-07]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=53.9, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=47.8, Expect=3e-06]} {RNA1310_39474.1} {RNA815_33128} |
7. | MligTC455_47613 | 35 | 0.72 | Mlig455_002169, Mlig455_002268 | Neo: - Age: Up-Down-Down |
CASP8 | 2.9 | - | - | 0.961 | - | 0.956 | 0.983 | Mlig455_002169 {REF} {Length: 2630} {Pfam: Caspase domain [PF00656.24, score=102.9]; Ankyrin repeats (3 copies) [PF12796.9, score=88.0]; Ankyrin repeats (many copies) [PF13857.8, score=71.4]; Ankyrin repeat [PF00023.32, score=59.2]; Ankyrin repeats (many copies) [PF13637.8, score=56.4]; Ankyrin repeat [PF13606.8, score=27.9]} {Human: ENSG00000064012, CASP8, caspase 8, [Score=132, Expect=4e-33]; ENSG00000132906, CASP9, caspase 9, [Score=129, Expect=1e-32]; ENSG00000165806, CASP7, caspase 7, [Score=127, Expect=3e-32]} {Mouse: ENSMUSG00000026029, Casp8, caspase 8, [Score=135, Expect=2e-34]} {Dmel: FBgn0028381, Decay, Death executioner caspase related to Apopain/Yama, [Score=101, Expect=1e-23]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=94.7, Expect=2e-21]} {Smed: dd_Smed_v6_4986_0_1, dd_Smed_v6_4986_0_1, [Score=124, Expect=1e-32]} {RNA1310_16714.1} {RNA815_15476} Mlig455_002268 {REF} {Length: 2678} {Pfam: Caspase domain [PF00656.24, score=103.1]; Ankyrin repeats (many copies) [PF13857.8, score=75.2]; Ankyrin repeats (3 copies) [PF12796.9, score=60.1]; Ankyrin repeat [PF00023.32, score=57.0]; Ankyrin repeats (many copies) [PF13637.8, score=53.0]; Ankyrin repeat [PF13606.8, score=28.1]} {Human: ENSG00000064012, CASP8, caspase 8, [Score=131, Expect=7e-33]; ENSG00000132906, CASP9, caspase 9, [Score=129, Expect=8e-33]; ENSG00000164305, CASP3, caspase 3, [Score=127, Expect=9e-33]; ENSG00000165806, CASP7, caspase 7, [Score=127, Expect=8e-32]} {Mouse: ENSMUSG00000026029, Casp8, caspase 8, [Score=131, Expect=8e-33]} {Dmel: FBgn0028381, Decay, Death executioner caspase related to Apopain/Yama, [Score=100, Expect=2e-23]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=94.4, Expect=2e-21]} {Smed: dd_Smed_v6_4986_0_1, dd_Smed_v6_4986_0_1, [Score=124, Expect=3e-32]} {RNA1310_16714.1} {RNA815_15476} |
8. | MligTC455_50546 | 21 | 0.44 | Mlig455_045408 | Neo: - Age: - |
2.9 | - | - | 0.989 | - | 0.927 | 0.984 | Mlig455_045408 {REF} {Length: 1345} {RNA1310_102440} | |
9. | MligTC455_04786 | 26 | 0.55 | Mlig455_043817, Mlig455_047431 | Neo: - Age: - |
2.895 | - | - | 0.955 | - | 0.948 | 0.992 | Mlig455_043817 {REF} {Length: 319} {NoTransDecoderORF} {RNA1310_64690} Mlig455_047431 {REF} {Length: 2194} {Pfam: Glycine rich protein [PF12810.9, score=25.3]} {RNA1509_16377} {RNA1310_33363.2} {RNA815_25152} |
|
10. | MligTC455_19323 | 26 | 0.54 | Mlig455_065634 | Neo: - Age: - |
2.895 | - | - | 0.955 | - | 0.943 | 0.997 | Mlig455_065634 {REF} {Length: 1335} {RNA1310_46115} {RNA815_19768} | |
11. | MligTC455_49958 | 16 | 0.32 | Mlig455_014437, Mlig455_070189 | Neo: - Age: - |
2.895 | - | - | 0.979 | - | 0.916 | 1.000 | Mlig455_014437 {REF} {Length: 921} {RNA1310_45206} {RNA815_28788} Mlig455_070189 {REF} {Length: 739} {RNA1310_45206} {RNA815_28788} |
|
12. | MligTC455_48634 | 30 | 0.62 | Mlig455_006052, Mlig455_068060 | Neo: - Age: - |
ANGPTL4, FCN2 | 2.891 | - | - | 0.985 | - | 0.909 | 0.997 | Mlig455_006052 {REF} {Length: 2091} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=64.0]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=83.6, Expect=2e-17]} {Mouse: ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=71.6, Expect=9e-14]} {Dmel: FBgn0034160, CG5550, [Score=67.4, Expect=2e-12]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=62.0, Expect=2e-10]} {RNA1310_118683} Mlig455_068060 {REF} {Length: 1573} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.6]} {Human: ENSG00000167772, ANGPTL4, angiopoietin like 4, [Score=53.9, Expect=9e-08]} {Mouse: ENSMUSG00000028553, Angptl3, angiopoietin-like 3, [Score=50.4, Expect=9e-07]} {Dmel: FBgn0050280, CG30280, [Score=57.0, Expect=2e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=53.9, Expect=3e-08]} {RNA1310_87835} |
13. | MligTC455_18909 | 14 | 0.29 | Mlig455_033525 | Neo: - Age: - |
2.888 | - | - | 0.943 | - | 0.948 | 0.997 | Mlig455_033525 {REF} {Length: 1169} {RNA1310_56722} {RNA815_26444} | |
14. | MligTC455_11229 | 51 | 1.06 | Mlig455_054212 | Neo: - Age: - |
2.879 | - | - | 0.979 | - | 0.904 | 0.996 | Mlig455_054212 {REF} {Length: 1481} {RNA1310_23944} {RNA815_32018} | |
15. | MligTC455_38284 | 12 | 0.25 | Mlig455_015813 | Neo: - Age: - |
2.875 | - | - | 0.962 | - | 0.964 | 0.949 | Mlig455_015813 {REF} {Length: 1163} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=61.6, Expect=2e-11]} {RNA1310_89599} {RNA815_16968} | |
16. | MligTC455_11078 | 15 | 0.31 | Mlig455_045628 | Neo: - Age: - |
2.874 | - | - | 0.966 | - | 0.931 | 0.977 | Mlig455_045628 {REF} {Length: 2373} {Pfam: Polycystin cation channel [PF08016.14, score=25.4]} {RNA1310_39436.1} {RNA815_35444} | |
17. | MligTC455_37793 | 353 | 7.36 | Mlig455_066109, Mlig455_068663 | Neo: - Age: Up-Down-Down |
HMCN1 | 2.874 | - | - | 0.952 | - | 0.927 | 0.995 | Mlig455_066109 {REF} {Length: 7924} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=408.1]; Spondin-like TSP1 domain [PF19028.2, score=285.5]; Polycystin cation channel [PF08016.14, score=239.7]; PLAT/LH2 domain [PF01477.25, score=86.7]; Thrombospondin type 1 domain [PF19030.2, score=78.4]; Ion transport protein [PF00520.33, score=42.7]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=360, Expect=8e-99]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=363, Expect=7e-100]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=199, Expect=5e-51]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [RH, Score=306, Expect=4e-84]} {Smed: dd_Smed_v6_13975_0_1, dd_Smed_v6_13975_0_1, [RH, Score=944, Expect=0.0]} {RNA1509_9601} {RNA1310_488} {RNA815_1711} Mlig455_068663 {REF} {Length: 7866} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=423.7]; Spondin-like TSP1 domain [PF19028.2, score=299.7]; Thrombospondin type 1 domain [PF19030.2, score=92.3]; PLAT/LH2 domain [PF01477.25, score=23.1]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=338, Expect=1e-94]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=341, Expect=9e-96]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=189, Expect=2e-48]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [RH, Score=303, Expect=2e-84]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=282, Expect=3e-77]} {RNA1509_9601} {RNA1310_488} {RNA815_1711} |
18. | MligTC455_13171 | 25 | 0.53 | Mlig455_005963, Mlig455_005967 | Neo: - Age: - |
2.864 | - | - | 0.960 | - | 0.909 | 0.995 | Mlig455_005963 {REF} {Length: 2617} {RNA1509_20946} {RNA1310_146331} {RNA815_35450} Mlig455_005967 {REF} {Length: 1405} {Pfam: Lectin C-type domain [PF00059.23, score=20.7]} {RNA1509_20946} {RNA1310_146331} {RNA815_35450} |
|
19. | MligTC455_09697 | 52 | 1.08 | Mlig455_009478, Mlig455_061921 | Neo: - Age: - |
CD207 | 2.863 | - | - | 0.958 | - | 0.909 | 0.996 | Mlig455_009478 {REF} {Length: 1068} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Human: ENSG00000116031, CD207, CD207 molecule, [Score=48.5, Expect=5e-06]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=68.2, Expect=1e-13]} {RNA1310_33496.1} {RNA815_23317} Mlig455_061921 {REF} {Length: 776} {Pfam: Lectin C-type domain [PF00059.23, score=35.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=69.7, Expect=4e-14]} {RNA1310_33496.1} {RNA815_23317} |
20. | MligTC455_40852 | 128 | 2.66 | Mlig455_042301 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.671 Region-enriched R2: 6.158/0.00357 |
PKDREJ | 2.861 | - | - | 0.970 | - | 0.920 | 0.971 | Mlig455_042301 {REF} {Length: 11184} {Pfam: Polycystin cation channel [PF08016.14, score=273.5]; PKD domain [PF00801.22, score=86.2]; PLAT/LH2 domain [PF01477.25, score=67.1]; REJ domain [PF02010.17, score=66.8]; PKD domain [PF18911.2, score=62.3]; Ion transport protein [PF00520.33, score=45.4]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=283, Expect=2e-75]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=273, Expect=2e-72]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=158, Expect=3e-38]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=254, Expect=4e-67]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=514, Expect=2e-146]} {RNA1509_8046} {RNA1310_93, RNA1509_8046} {RNA1509_8046, RNA815_1216} |
21. | MligTC455_52232 | 92 | 1.92 | Mlig455_007894, Mlig455_008001 | Neo: - Age: logFC(26M/2M)=0.549 |
2.86 | - | - | 0.946 | - | 0.918 | 0.996 | Mlig455_007894 {REF} {Length: 1500} {RNA1310_22136} {RNA815_18832} Mlig455_008001 {REF} {Length: 1450} {Pfam: PAN domain [PF00024.28, score=18.9]} {RNA1310_22136} {RNA815_18832} |
|
22. | MligTC455_36014 | 1671 | 34.81 | Mlig455_004210 | Neo: - Age: Up-Up-Down Region-enriched R2: 2.167/0.00118 |
PLA2G3 | 2.854 | - | - | 0.928 | - | 0.947 | 0.979 | Mlig455_004210 {REF} {Length: 1631} {Pfam: Phospholipase A2 [PF05826.14, score=106.6]} {Human: ENSG00000100078, PLA2G3, phospholipase A2 group III, [RH, Score=97.4, Expect=6e-23]} {Mouse: ENSMUSG00000034579, Pla2g3, phospholipase A2, group III, [RH, Score=99.4, Expect=5e-24]} {Dmel: FBgn0030013, GIIIspla2, Phospholipase A2 group III, [RH, Score=97.8, Expect=5e-25]} {Smed: dd_Smed_v6_3851_0_2, dd_Smed_v6_3851_0_2, [RH, Score=103, Expect=4e-27]} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1310_22647, RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881, RNA815_9445} |
23. | MligTC455_19456 | 34 | 0.7 | Mlig455_038677 | Neo: - Age: - |
2.853 | - | - | 0.972 | - | 0.947 | 0.934 | Mlig455_038677 {REF} {Length: 1621} {TRANSSPLICED} {Smed: dd_Smed_v6_15258_0_1, dd_Smed_v6_15258_0_1, [Score=49.3, Expect=4e-07]} {RNA1310_112748} | |
24. | MligTC455_50355 | 38 | 0.79 | Mlig455_057631 | Neo: - Age: - Region-enriched R2: 7.639/0.01837 |
2.853 | - | - | 0.979 | - | 0.879 | 0.995 | Mlig455_057631 {REF} {Length: 1003} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1310_44307} {RNA815_33128} | |
25. | MligTC455_13130 | 40 | 0.83 | Mlig455_032511, Mlig455_068691 | Neo: - Age: - |
WSCD2 | 2.847 | - | - | 0.990 | - | 0.883 | 0.974 | Mlig455_032511 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=40.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.4, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {RNA1310_39527} {RNA815_19067} Mlig455_068691 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=41.8]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.1, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=49.7, Expect=9e-07]; ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=4e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=62.0, Expect=6e-11]} {RNA1310_39527} {RNA815_19067} |
26. | MligTC455_18499 | 24 | 0.5 | Mlig455_012628 | Neo: - Age: - |
2.839 | - | - | 0.917 | - | 0.951 | 0.971 | Mlig455_012628 {REF} {Length: 1340} {Smed: dd_Smed_v6_500_0_1, dd_Smed_v6_500_0_1, [Score=60.5, Expect=1e-10]} {RNA1310_107419} {RNA815_46554} | |
27. | MligTC455_25858 | 48 | 1 | Mlig455_005649, Mlig455_005698, Mlig455_008659 | Neo: - Age: - |
2.837 | - | - | 0.915 | - | 0.923 | 0.999 | Mlig455_005649 {REF} {Length: 1060} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=27.0]} {RNA1509_35414} {RNA1310_2501.1} {RNA815_9496.1} Mlig455_005698 {REF} {Length: 1505} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=26.8]} {RNA1509_35414} {RNA1310_2501.1} {RNA815_9496.1} Mlig455_008659 {REF} {Length: 1151} {TRANSSPLICED} {Pfam: haloacid dehalogenase-like hydrolase [PF08282.14, score=19.9]} {RNA1509_25258} {RNA1310_56236} {RNA815_9496.1} |
|
28. | MligTC455_32311 | 54 | 1.12 | Mlig455_026929 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.612 Region-enriched R2: 7.331/0.00256 |
2.833 | - | - | 0.993 | - | 0.879 | 0.961 | Mlig455_026929 {REF} {Length: 1796} {Pfam: PAN domain [PF00024.28, score=22.2]} {RNA1310_30037.1} {RNA815_37290} | |
29. | MligTC455_15679 | 88 | 1.82 | Mlig455_057219 | Neo: - Age: Down-Up-Up |
WSCD2 | 2.831 | - | - | 0.946 | - | 0.888 | 0.997 | Mlig455_057219 {REF} {Length: 1035} {Pfam: WSC domain [PF01822.21, score=55.1]; PAN domain [PF00024.28, score=27.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.8, Expect=2e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=51.6, Expect=3e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.5, Expect=5e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
30. | MligTC455_42510 | 125 | 2.6 | Mlig455_025998, Mlig455_070424 | Neo: - |
2.831 | - | - | 0.978 | - | 0.859 | 0.994 | Mlig455_025998 {REF} {Length: 1369} {RNA1310_73875.1} Mlig455_070424 {REF} {Length: 1082} {RNA1310_73875.1} |
|
31. | MligTC455_37792 | 210 | 4.38 | Mlig455_024774 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.926 Region-enriched R2: 6.055/0.00271 |
PKD1L2 | 2.83 | - | - | 0.973 | - | 0.911 | 0.946 | Mlig455_024774 {REF} {Length: 6374} {Pfam: Polycystin cation channel [PF08016.14, score=224.6]; PLAT/LH2 domain [PF01477.25, score=66.8]; Ion transport protein [PF00520.33, score=30.8]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=179, Expect=9e-45]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=187, Expect=3e-47]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=109, Expect=1e-23]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=187, Expect=2e-47]} {Smed: dd_Smed_v6_13975_0_1, dd_Smed_v6_13975_0_1, [Score=902, Expect=0.0]} {RNA1509_46134} {RNA1310_488} {RNA815_1711} |
32. | MligTC455_39096 | 110 | 2.29 | Mlig455_019781, Mlig455_019803 | Neo: - Age: - |
2.83 | - | - | 0.954 | - | 0.879 | 0.997 | Mlig455_019781 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=65.0]} {RNA1310_34740} {RNA815_15663} Mlig455_019803 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.1]} {RNA1310_34740} {RNA815_15663} |
|
33. | MligTC455_26255 | 126 | 2.63 | Mlig455_053706 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.424/0.00107 |
FZD5 | 2.829 | - | - | 0.991 | - | 0.839 | 0.999 | Mlig455_053706 {REF} {Length: 3671} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=393.1]; Fz domain [PF01392.24, score=105.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [RH, Score=607, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=600, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [RH, Score=562, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [RH, Score=412, Expect=5e-137]} {Smed: dd_Smed_v6_11823_0_1, dd_Smed_v6_11823_0_1, [RH, Score=551, Expect=0.0]} {RNA1509_49831} {RNA1310_28187, RNA1509_49831} {RNA1509_49831, RNA815_16996} |
34. | MligTC455_39985 | 28 | 0.58 | Mlig455_022339, Mlig455_022351 | Neo: - Age: - |
2.821 | - | - | 0.937 | - | 0.887 | 0.997 | Mlig455_022339 {REF} {Length: 783} {RNA1509_47318} {RNA1310_125793} {RNA815_2914.1} Mlig455_022351 {REF} {Length: 1105} {Pfam: WSC domain [PF01822.21, score=64.2]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=64.7, Expect=8e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=51.6, Expect=2e-07]} {RNA1310_59980.1} {RNA815_55549} |
|
35. | MligTC455_44646 | 193 | 4.01 | Mlig455_013515 | Neo: - Age: Down-Up-Down |
SCNN1B | 2.817 | - | - | 0.959 | - | 0.903 | 0.955 | Mlig455_013515 {REF} {Length: 2272} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=308.7]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [RH, Score=191, Expect=3e-52]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [RH, Score=188, Expect=3e-51]} {Dmel: FBgn0030795, ppk28, pickpocket 28, [Score=68.2, Expect=1e-11]} {Celegans: WBGene00012137, asic-2, Degenerin-like protein asic-2, [Score=143, Expect=2e-36]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [Score=175, Expect=2e-47]} {RNA1509_52917} {RNA1310_12013.1, RNA1509_52917} {RNA1509_52917, RNA815_4777} |
36. | MligTC455_18683 | 419 | 8.74 | Mlig455_069928 | Neo: - Age: - Region-specific R2: 6.066 Region-enriched R2: 4.921/0.00217 |
2.814 | - | - | 0.970 | - | 0.848 | 0.996 | Mlig455_069928 {REF} {Length: 845} {RNA1509_25826} {RNA1310_42757} {RNA815_23874} | |
37. | MligTC455_19322 | 47 | 0.98 | Mlig455_060292 | Neo: - Age: - Region-enriched R5: 4.828/0.04092 |
2.807 | - | - | 0.954 | - | 0.913 | 0.940 | Mlig455_060292 {REF} {Length: 1265} {RNA1310_61465} {RNA815_19768} | |
38. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 2.807 | - | - | 0.941 | - | 0.878 | 0.988 | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
39. | MligTC455_45039 | 168 | 3.49 | Mlig455_040482, Mlig455_040487 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.332/0.02336 |
2.807 | - | - | 0.969 | - | 0.843 | 0.995 | Mlig455_040482 {REF} {Length: 1774} {RNA1310_20941} {RNA815_45079} Mlig455_040487 {REF} {Length: 5763} {tRNA: Val(CAC),pseudo, score=20.2} {Celegans: WBGene00022195, Y71H2B.5, [Score=146, Expect=8e-36]} {Smed: dd_Smed_v6_16438_0_2, dd_Smed_v6_16438_0_2, [Score=188, Expect=1e-49]} {RNA1509_21228} {RNA1310_20941} {RNA815_45079} |
|
40. | MligTC455_08853 | 22 | 0.45 | Mlig455_068998 | Neo: - Age: - |
2.806 | - | - | 0.970 | - | 0.931 | 0.905 | Mlig455_068998 {REF} {Length: 1981} {Pfam: Glycine rich protein [PF12810.9, score=35.1]} {RNA1310_75162} {RNA815_38988} | |
41. | MligTC455_35583 | 48 | 0.99 | Mlig455_009953 | Neo: - Age: - |
2.806 | - | - | 0.973 | - | 0.839 | 0.994 | Mlig455_009953 {REF} {Length: 919} {Pfam: Lectin C-type domain [PF00059.23, score=25.9]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=61.6, Expect=2e-11]} {RNA1509_20946} {RNA1310_71370} {RNA815_4785.4} | |
42. | MligTC455_43581 | 177 | 3.68 | Mlig455_042725, Mlig455_042827, Mlig455_063146 | Neo: - Age: Up-Down-Down |
GRIA2 | 2.805 | - | - | 0.949 | - | 0.885 | 0.971 | Mlig455_042725 {REF} {Length: 3074} {Pfam: Ligand-gated ion channel [PF00060.28, score=104.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.7]; Receptor family ligand binding region [PF01094.30, score=33.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.7]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=153, Expect=1e-37]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=149, Expect=2e-36]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=147, Expect=7e-36]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=152, Expect=2e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=148, Expect=3e-36]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=147, Expect=8e-36]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=2e-35]} {Dmel: FBgn0038837, CG3822, [Score=140, Expect=5e-34]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=253, Expect=2e-76]} {RNA1310_25150} {RNA815_13942} Mlig455_042827 {REF} {Length: 2869} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.9]; Receptor family ligand binding region [PF01094.30, score=49.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.3]; Iron-containing alcohol dehydrogenase [PF13685.8, score=18.6]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=125, Expect=6e-29]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=122, Expect=5e-28]; ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=121, Expect=7e-28]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=120, Expect=2e-27]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=125, Expect=5e-29]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=122, Expect=4e-28]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=121, Expect=1e-27]; ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=120, Expect=1e-27]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=119, Expect=3e-27]} {Dmel: FBgn0039927, CG11155, [Score=127, Expect=7e-30]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=103, Expect=1e-22]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=217, Expect=2e-63]} {RNA1310_25150} {RNA815_13942} Mlig455_063146 {REF} {Length: 2444} {Pfam: Receptor family ligand binding region [PF01094.30, score=35.8]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=82.4, Expect=1e-16]} {RNA1310_25150} {RNA815_13999} |
43. | MligTC455_45019 | 64 | 1.33 | Mlig455_009383, Mlig455_036937 | Neo: - Age: - |
WSCD2 | 2.805 | - | - | 0.952 | - | 0.941 | 0.912 | Mlig455_009383 {REF} {Length: 854} {Pfam: WSC domain [PF01822.21, score=58.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=6e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=60.5, Expect=2e-10]} {RNA1310_43246} {RNA815_43085} Mlig455_036937 {REF} {Length: 858} {Pfam: WSC domain [PF01822.21, score=58.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=6e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=60.5, Expect=2e-10]} {RNA1310_43246} {RNA815_43085} |
44. | MligTC455_43452 | 29 | 0.6 | Mlig455_013155 | Neo: - Age: - |
2.794 | - | - | 0.994 | - | 0.802 | 0.998 | Mlig455_013155 {REF} {Length: 920} {Pfam: Lectin C-type domain [PF00059.23, score=25.4]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=57.0, Expect=8e-10]} {RNA1509_20946} {RNA1310_57972} {RNA815_4785.4} | |
45. | MligTC455_42706 | 23 | 0.47 | Mlig455_069209 | Neo: - Age: - |
2.793 | - | - | 0.865 | - | 0.933 | 0.995 | Mlig455_069209 {REF} {Length: 1678} {RNA1310_62984} {RNA815_26444} | |
46. | MligTC455_15450 | 19 | 0.39 | Mlig455_006618 | Neo: - Age: - |
2.785 | - | - | 0.962 | - | 0.826 | 0.997 | Mlig455_006618 {REF} {Length: 653} {Pfam: WSC domain [PF01822.21, score=30.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.5, Expect=7e-09]} {RNA1310_35396.1} {RNA815_56551} | |
47. | MligTC455_39890 | 162 | 3.37 | Mlig455_047281, Mlig455_047331, Mlig455_069333 | Neo: - Age: - Region-enriched R2: 6.097/0.00148 |
PLSCR1 | 2.782 | - | - | 0.961 | - | 0.827 | 0.994 | Mlig455_047281 {REF} {Length: 1404} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_047331 {REF} {Length: 1395} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_069333 {REF} {Length: 1416} {Pfam: Scramblase [PF03803.17, score=248.7]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=226, Expect=1e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=228, Expect=2e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=223, Expect=1e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=224, Expect=2e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=4e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=304, Expect=2e-103]} {RNA1310_29769} {RNA815_41335} |
48. | MligTC455_46708 | 362 | 7.53 | Mlig455_045334 | Neo: - Age: - Region-enriched R2: 2.783/0.01800 |
2.782 | - | - | 0.964 | - | 0.858 | 0.960 | Mlig455_045334 {REF} {Length: 1243} {RNA1509_51601} {RNA1310_43115.2, RNA1509_51601} {RNA1509_51601, RNA815_21402.1} | |
49. | MligTC455_43488 | 21 | 0.43 | Mlig455_056742 | Neo: - Age: - |
2.778 | - | - | 0.864 | - | 0.917 | 0.997 | Mlig455_056742 {REF} {Length: 882} {Pfam: WSC domain [PF01822.21, score=53.2]; PAN domain [PF00024.28, score=28.9]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=7e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=54.3, Expect=3e-08]} {RNA1310_48783} {RNA815_22910} | |
50. | MligTC455_44380 | 28 | 0.58 | Mlig455_000679, Mlig455_000682, Mlig455_000734 | Neo: - Age: - |
2.778 | - | - | 0.936 | - | 0.846 | 0.996 | Mlig455_000679 {REF} {Length: 966} {Pfam: PAN domain [PF00024.28, score=22.4]} {RNA1310_44307} {RNA815_33128} Mlig455_000682 {REF} {Length: 1005} {Pfam: WSC domain [PF01822.21, score=41.4]; PAN domain [PF00024.28, score=21.7]} {RNA1310_44307} {RNA815_33128} Mlig455_000734 {REF} {Length: 1006} {Pfam: WSC domain [PF01822.21, score=41.4]; PAN domain [PF00024.28, score=21.7]} {RNA1310_44307} {RNA815_33128} |
|
51. | MligTC455_21755 | 70 | 1.47 | Mlig455_021213 | Neo: - Age: - |
2.775 | - | - | 0.832 | - | 0.947 | 0.996 | Mlig455_021213 {REF} {Length: 4215} {Pfam: F5/8 type C domain [PF00754.27, score=55.5]} {RNA1509_2515} {RNA1310_33166} {RNA815_14716} | |
52. | MligTC455_14904 | 4225 | 88.01 | Mlig455_037596 | Neo: - Age: logFC(26M/2M)=0.385 Region-enriched R8: 1.541/0.00053 |
2.774 | - | - | 0.938 | - | 0.871 | 0.965 | Mlig455_037596 {REF} {Length: 2914} {Dmel: FBgn0034294, Muc55B, Mucin 55B, [Score=59.3, Expect=3e-09]} {RNA1509_17730, RNA1509_4337} {RNA1310_7259, RNA1509_17730} {RNA1509_17730, RNA815_206} | |
53. | MligTC455_46637 | 18 | 0.37 | Mlig455_010742 | Neo: Irradiation Age: Down-Up-Down Region-enriched R2: 6.787/0.03510 |
LMX1B | 2.774 | - | - | 0.912 | - | 0.870 | 0.992 | Mlig455_010742 {REF} {Length: 2975} {Pfam: LIM domain [PF00412.24, score=101.8]; Homeodomain [PF00046.31, score=64.1]; Homeobox KN domain [PF05920.13, score=27.5]; Auxin canalisation [PF05703.13, score=20.5]} {Human: ENSG00000136944, LMX1B, LIM homeobox transcription factor 1 beta, [RH, Score=241, Expect=3e-76]; ENSG00000162761, LMX1A, LIM homeobox transcription factor 1 alpha, [RH, Score=238, Expect=3e-75]} {Mouse: ENSMUSG00000038765, Lmx1b, LIM homeobox transcription factor 1 beta, [RH, Score=241, Expect=2e-76]; ENSMUSG00000026686, Lmx1a, LIM homeobox transcription factor 1 alpha, [RH, Score=233, Expect=2e-73]} {Dmel: FBgn0052105, Lmx1a, LIM homeobox transcription factor 1 alpha, [RH, Score=236, Expect=7e-72]} {Celegans: WBGene00002988, lim-6, LIM domain family, [Score=182, Expect=1e-54]} {Smed: dd_Smed_v6_13371_0_1, dd_Smed_v6_13371_0_1, [RH, Score=171, Expect=2e-49]} {RNA1509_10207} {RNA1310_5646.2} {RNA815_25330} |
54. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 2.771 | - | - | 0.959 | - | 0.822 | 0.990 | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
55. | MligTC455_52482 | 22 | 0.46 | Mlig455_042671 | Neo: - Age: - |
2.768 | - | - | 0.967 | - | 0.831 | 0.970 | Mlig455_042671 {REF} {Length: 2390} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=150.1]} {Smed: dd_Smed_v6_31771_0_1, dd_Smed_v6_31771_0_1, [Score=71.2, Expect=6e-13]} {RNA1310_47540} {RNA815_16144} | |
56. | MligTC455_47905 | 56 | 1.16 | Mlig455_037694 | Neo: - Age: - |
2.763 | - | - | 0.908 | - | 0.868 | 0.987 | Mlig455_037694 {REF} {Length: 2503} {RNA1310_36768.1} {RNA815_27683} | |
57. | MligTC455_41540 | 190 | 3.96 | Mlig455_060056 | Neo: - Age: - Region-enriched R2: 6.605/0.00196 |
GLUL | 2.762 | - | - | 0.974 | - | 0.791 | 0.997 | Mlig455_060056 {REF} {Length: 1355} {Pfam: Glutamine synthetase, catalytic domain [PF00120.26, score=57.3]; Glutamine synthetase, beta-Grasp domain [PF03951.21, score=47.5]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=511, Expect=1e-180]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=511, Expect=0.0]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=511, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=515, Expect=0.0]} {Smed: dd_Smed_v6_896_0_1, dd_Smed_v6_896_0_1, [RH, Score=545, Expect=0.0]} {RNA1509_47000} {RNA1310_22329.2} {RNA815_4116.6} |
58. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
2.762 | - | - | 0.973 | - | 0.792 | 0.997 | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
59. | MligTC455_45495 | 988 | 20.58 | Mlig455_010003 | Neo: - Age: logFC(26M/2M)=0.384 Region-enriched R2: 2.517/0.00003 |
CAV2 | 2.76 | - | - | 0.903 | - | 0.867 | 0.990 | Mlig455_010003 {REF} {Length: 748} {Pfam: Caveolin [PF01146.19, score=125.0]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=85.5, Expect=3e-21]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=89.4, Expect=7e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=79.0, Expect=2e-18]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [RH, Score=153, Expect=1e-48]} {RNA1509_20287} {RNA1310_50581.1} {RNA815_31873} |
60. | MligTC455_35701 | 66 | 1.37 | Mlig455_010067, Mlig455_063254, Mlig455_063279 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.716/0.02468 |
2.757 | - | - | 0.967 | - | 0.801 | 0.989 | Mlig455_010067 {REF} {Length: 2624} {Pfam: Polycystin cation channel [PF08016.14, score=46.7]} {RNA1310_62521} Mlig455_063254 {REF} {Length: 2738} {Pfam: Polycystin cation channel [PF08016.14, score=43.3]; Lipopolysaccharide assembly protein A domain [PF06305.13, score=18.4]} {RNA1509_7418} {RNA1310_62521} {RNA815_3659} Mlig455_063279 {REF} {Length: 2677} {Pfam: Polycystin cation channel [PF08016.14, score=46.0]} {RNA1310_62521} |
|
61. | MligTC455_24549 | 20 | 0.42 | Mlig455_032034 | Neo: - Age: - |
ROBO3 | 2.748 | - | - | 0.958 | - | 0.849 | 0.941 | Mlig455_032034 {REF} {Length: 6931} {Pfam: Immunoglobulin domain [PF13927.8, score=135.0]; Immunoglobulin I-set domain [PF07679.18, score=120.2]; Immunoglobulin domain [PF00047.27, score=83.5]; Immunoglobulin domain [PF13895.8, score=81.9]; Immunoglobulin V-set domain [PF07686.19, score=75.7]; Fibronectin type III domain [PF00041.23, score=23.6]; Immunoglobulin domain [PF18452.3, score=19.8]} {Human: ENSG00000154134, ROBO3, roundabout guidance receptor 3, [Score=166, Expect=9e-41]; ENSG00000169855, ROBO1, roundabout guidance receptor 1, [Score=165, Expect=1e-40]; ENSG00000185008, ROBO2, roundabout guidance receptor 2, [Score=164, Expect=2e-40]} {Mouse: ENSMUSG00000022883, Robo1, roundabout guidance receptor 1, [Score=194, Expect=1e-49]} {Dmel: FBgn0005631, robo1, roundabout 1, [Score=147, Expect=2e-35]} {Celegans: WBGene00004729, sax-3, [Score=146, Expect=3e-35]} {Smed: dd_Smed_v6_8494_0_2, dd_Smed_v6_8494_0_2, [Score=251, Expect=5e-68]} {RNA1310_77723} {RNA815_50892} |
62. | MligTC455_49334 | 86 | 1.78 | Mlig455_037751 | Neo: - Age: - |
2.745 | - | - | 0.791 | - | 0.957 | 0.997 | Mlig455_037751 {REF} {Length: 708} {RNA1509_25826} {RNA1310_47741} {RNA815_23874} | |
63. | MligTC455_43961 | 30 | 0.62 | Mlig455_027626 | Neo: - Age: - |
2.744 | - | - | 0.803 | - | 0.944 | 0.997 | Mlig455_027626 {REF} {Length: 602} {Pfam: PAN domain [PF00024.28, score=26.5]; PAN domain [PF14295.8, score=21.8]} {RNA1310_35396.1} {RNA815_23500} | |
64. | MligTC455_41339 | 61 | 1.27 | Mlig455_021120 | Neo: - Age: - |
2.74 | - | - | 0.981 | - | 0.759 | 1.000 | Mlig455_021120 {REF} {Length: 294} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_118897} {RNA815_62550} | |
65. | MligTC455_40751 | 206 | 4.29 | Mlig455_045754 | Neo: - Age: Down-Up-Down |
2.74 | - | - | 0.966 | - | 0.890 | 0.884 | Mlig455_045754 {REF} {Length: 1094} {Pfam: Lectin C-type domain [PF00059.23, score=30.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=55.1, Expect=4e-09]} {RNA1310_36556.1} {RNA815_16968} | |
66. | MligTC455_20722 | 36 | 0.74 | Mlig455_001696, Mlig455_066078, Mlig455_066120 | Neo: - Age: - |
2.737 | - | - | 0.954 | - | 0.806 | 0.977 | Mlig455_001696 {REF} {Length: 1535} {RNA1310_134737} {RNA815_57224} Mlig455_066078 {REF} {Length: 1438} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} {RNA1310_134737} {RNA815_57224} Mlig455_066120 {REF} {Length: 1438} {Pfam: Glycine rich protein [PF12810.9, score=25.9]} {RNA1310_134737} {RNA815_57224} |
|
67. | MligTC455_18682 | 1190 | 24.79 | Mlig455_037756 | Neo: - Age: Up-Down-Down Region-specific R2: 4.877 Region-enriched R2: 4.609/0.00000 |
2.736 | - | - | 0.965 | - | 0.774 | 0.997 | Mlig455_037756 {REF} {Length: 1188} {RNA1509_25826} {RNA1310_42757} {RNA815_23874} | |
68. | MligTC455_17464 | 409 | 8.52 | Mlig455_048989, Mlig455_049006, Mlig455_067762 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.512 Regeneration-downregulated BL: -7.800 Regeneration-depleted BL: -7.800 |
2.734 | - | - | 0.980 | - | 0.761 | 0.993 | Mlig455_048989 {REF} {Length: 1272} {RNA1310_37715} {RNA815_39767} Mlig455_049006 {REF} {Length: 1028} {RNA1310_37715} {RNA815_39767} Mlig455_067762 {REF} {Length: 1353} {RNA1310_37715} {RNA815_39767} |
|
69. | MligTC455_18775 | 130 | 2.71 | Mlig455_043349 | Neo: - Age: - |
2.731 | - | - | 0.971 | - | 0.775 | 0.985 | Mlig455_043349 {REF} {Length: 1583} {RNA1310_56123.1} {RNA815_28679} | |
70. | MligTC455_24515 | 14 | 0.28 | Mlig455_033346, Mlig455_033365 | Neo: - Age: - |
HTR1B | 2.726 | - | - | 0.983 | - | 0.756 | 0.987 | Mlig455_033346 {REF} {Length: 1493} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.5]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=4e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=189, Expect=2e-54]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=176, Expect=4e-50]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=218, Expect=5e-66]} {RNA1310_132724} Mlig455_033365 {REF} {Length: 1935} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=24.0]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=7e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=191, Expect=4e-55]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=178, Expect=8e-51]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=216, Expect=2e-65]} {RNA1310_132724} |
71. | MligTC455_39047 | 39 | 0.81 | Mlig455_037921, Mlig455_038983 | Neo: - Age: - |
TNN | 2.714 | - | - | 0.904 | - | 0.819 | 0.991 | Mlig455_037921 {REF} {Length: 4077} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=111.9]} {Human: ENSG00000120332, TNN, tenascin N, [Score=95.5, Expect=1e-21]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=94.7, Expect=2e-21]} {Dmel: FBgn0050280, CG30280, [Score=87.0, Expect=3e-20]} {Celegans: WBGene00020516, T15B7.1, [Score=52.0, Expect=2e-07]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=73.6, Expect=1e-14]} {RNA1509_16377} {RNA1310_5710.1} {RNA815_14744.1} Mlig455_038983 {REF} {Length: 2023} {RNA1310_108685} {RNA815_54007} |
72. | MligTC455_50566 | 40 | 0.84 | Mlig455_061499 | Neo: - Age: - Region-enriched R2: 5.243/0.02447 |
2.712 | - | - | 0.999 | - | 0.802 | 0.911 | Mlig455_061499 {REF} {Length: 484} {NoTransDecoderORF} {RNA1310_94077} {RNA815_47403} | |
73. | MligTC455_09455 | 51 | 1.06 | Mlig455_029990 | Neo: - Age: - Region-enriched R2: 4.710/0.00601 |
2.71 | - | - | 0.891 | - | 0.836 | 0.983 | Mlig455_029990 {REF} {Length: 3817} {Mouse: ENSMUSG00000090546, Cdr1, cerebellar degeneration related antigen 1, [Score=63.2, Expect=8e-10]} {Celegans: WBGene00013762, Y113G7B.12, [Score=58.2, Expect=2e-08]} {RNA1509_44134} {RNA1310_28496} {RNA815_11143} | |
74. | MligTC455_29012 | 227 | 4.74 | Mlig455_004572 | Neo: - Age: Down-Down-Up |
TMEM30A | 2.705 | - | - | 0.969 | - | 0.770 | 0.966 | Mlig455_004572 {REF} {Length: 3160} {TRANSSPLICED} {Pfam: LEM3 (ligand-effect modulator 3) family / CDC50 family [PF03381.17, score=265.5]} {Human: ENSG00000112697, TMEM30A, transmembrane protein 30A, [RH, Score=234, Expect=7e-73]} {Mouse: ENSMUSG00000032328, Tmem30a, transmembrane protein 30A, [RH, Score=241, Expect=7e-76]} {Dmel: FBgn0030752, CG9947, [RH, Score=294, Expect=9e-97]} {Celegans: WBGene00019946, chat-1, CDC50 family protein chat-1, [Score=246, Expect=3e-78]} {Smed: dd_Smed_v6_6430_0_1, dd_Smed_v6_6430_0_1, [Score=275, Expect=2e-89]} {RNA1509_38539} {RNA1310_9371} {RNA815_12157} |
75. | MligTC455_52640 | 56 | 1.18 | Mlig455_045103 | Neo: - Age: - Region-enriched R2: 6.488/0.02940 |
2.702 | - | - | 0.991 | - | 0.745 | 0.966 | Mlig455_045103 {REF} {Length: 2443} {Pfam: F5/8 type C domain [PF00754.27, score=19.1]} {RNA1509_57504} {RNA1310_27303.2} {RNA815_32964} | |
76. | MligTC455_19235 | 18 | 0.38 | Mlig455_013768 | Neo: - Age: - |
2.701 | - | - | 0.967 | - | 0.753 | 0.981 | Mlig455_013768 {REF} {Length: 2312} {Pfam: Glycine rich protein [PF12810.9, score=36.9]; PAN domain [PF00024.28, score=24.7]} {RNA1310_126710} {RNA815_35307} | |
77. | MligTC455_50253 | 44 | 0.92 | Mlig455_031495 | Neo: - Age: - |
GABRB2 | 2.698 | - | - | 0.967 | - | 0.736 | 0.995 | Mlig455_031495 {REF} {Length: 2129} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=58.3]} {Human: ENSG00000145864, GABRB2, gamma-aminobutyric acid type A receptor beta2 subunit, [Score=71.2, Expect=6e-14]} {Mouse: ENSMUSG00000007653, Gabrb2, gamma-aminobutyric acid (GABA) A receptor, subunit beta 2, [Score=67.8, Expect=1e-12]; ENSMUSG00000029212, Gabrb1, gamma-aminobutyric acid (GABA) A receptor, subunit beta 1, [Score=67.4, Expect=1e-12]} {Dmel: FBgn0024963, GluClalpha, [Score=54.3, Expect=3e-08]} {Celegans: WBGene00001594, glc-4, Glutamate-gated ChLoride channel, [Score=66.6, Expect=2e-12]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=70.1, Expect=9e-14]} {RNA1310_46931} {RNA815_25428} |
78. | MligTC455_09456 | 47 | 0.97 | Mlig455_029993 | Neo: - Age: - Region-enriched R2: 5.041/0.00960 |
2.69 | - | - | 0.966 | - | 0.738 | 0.986 | Mlig455_029993 {REF} {Length: 3167} {RNA1509_44134} {RNA1310_31411} {RNA815_45870} | |
79. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
2.683 | - | - | 0.964 | - | 0.723 | 0.996 | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
80. | MligTC455_33040 | 203 | 4.23 | Mlig455_032497 | Neo: - Age: logFC(26M/2M)=0.515 Region-enriched R2: 4.005/0.00408 |
PKD2L1 | 2.674 | - | - | 0.965 | - | 0.730 | 0.979 | Mlig455_032497 {REF} {Length: 3318} {Pfam: Polycystin cation channel [PF08016.14, score=293.1]; Ion transport protein [PF00520.33, score=39.7]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=236, Expect=4e-66]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=261, Expect=3e-73]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=131, Expect=5e-31]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=180, Expect=1e-47]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=641, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
81. | MligTC455_44176 | 89 | 1.85 | Mlig455_022911 | Neo: - Age: - |
TNKS | 2.673 | - | - | 0.968 | - | 0.746 | 0.959 | Mlig455_022911 {REF} {Length: 1883} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=67.0]; Ankyrin repeats (3 copies) [PF12796.9, score=64.6]; Ankyrin repeats (many copies) [PF13857.8, score=59.2]; Ankyrin repeat [PF13606.8, score=50.9]; Ankyrin repeat [PF00023.32, score=50.1]} {Human: ENSG00000173273, TNKS, tankyrase, [Score=57.8, Expect=3e-08]; ENSG00000285372, AC270292.3, tankyrase, [Score=56.6, Expect=7e-08]; ENSG00000236759, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000238134, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000204371, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000206376, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000227333, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000232045, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000224143, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000029534, ANK1, ankyrin 1, [Score=55.5, Expect=2e-07]} {Mouse: ENSMUSG00000095294, Gm21119, predicted gene, 21119, [Score=57.8, Expect=1e-08]; ENSMUSG00000096265, 4930467E23Rik, RIKEN cDNA 4930467E23 gene, [Score=57.8, Expect=1e-08]; ENSMUSG00000031529, Tnks, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase, [Score=57.8, Expect=2e-08]; ENSMUSG00000074449, Gm15319, predicted gene 15319, [Score=57.4, Expect=1e-08]; ENSMUSG00000013787, Ehmt2, euchromatic histone lysine N-methyltransferase 2, [Score=55.8, Expect=9e-08]; ENSMUSG00000063932, Poteg, POTE ankyrin domain family, member G, [Score=55.5, Expect=8e-08]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=55.5, Expect=1e-07]; ENSMUSG00000110591, Gm31371, predicted gene, 31371, [Score=55.5, Expect=4e-08]; ENSMUSG00000106824, Gm7697, predicted gene 7697, [Score=55.1, Expect=8e-08]; ENSMUSG00000107280, Gm9495, predicted gene 9495, [Score=55.1, Expect=8e-08]} {Dmel: FBgn0040752, Prosap, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=53.5, Expect=2e-07]} {Smed: dd_Smed_v6_2072_0_22, dd_Smed_v6_2072_0_22, [Score=62.0, Expect=4e-10]} {RNA1509_39040} {RNA1310_19494} {RNA815_14632} |
82. | MligTC455_35381 | 14 | 0.29 | Mlig455_016857 | Neo: - Age: logFC(26M/2M)=-1.315 |
HMCN1 | 2.667 | - | - | 0.706 | - | 0.964 | 0.997 | Mlig455_016857 {REF} {Length: 4332} {Pfam: Fibronectin type II domain [PF00040.21, score=44.0]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=106, Expect=3e-22]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=112, Expect=2e-24]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=65.9, Expect=2e-10]} {Celegans: WBGene00011880, T21B6.3, [Score=80.9, Expect=4e-15]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=105, Expect=1e-22]} {RNA1509_59017} {RNA1310_52334} {RNA815_20741} |
83. | MligTC455_06015 | 22 | 0.45 | Mlig455_025599 | Neo: - Age: - |
2.662 | - | - | 0.942 | - | 0.723 | 0.997 | Mlig455_025599 {REF} {Length: 4401} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.9]; WSC domain [PF01822.21, score=18.9]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=50.8, Expect=3e-06]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=59.7, Expect=4e-09]} | |
84. | MligTC455_44177 | 70 | 1.46 | Mlig455_022828, Mlig455_022920 | Neo: - Age: - |
TNKS | 2.659 | - | - | 0.959 | - | 0.762 | 0.938 | Mlig455_022828 {REF} {Length: 1654} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=58.3]; Ankyrin repeats (many copies) [PF13637.8, score=51.4]; Ankyrin repeats (many copies) [PF13857.8, score=43.5]; Ankyrin repeat [PF00023.32, score=38.9]; Ankyrin repeat [PF13606.8, score=35.6]} {Dmel: FBgn0039955, CG41099, [Score=56.6, Expect=5e-08]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=53.1, Expect=4e-07]} {Smed: dd_Smed_v6_11252_0_1, dd_Smed_v6_11252_0_1, [Score=50.8, Expect=1e-06]} {RNA1509_39040} {RNA1310_886.1} {RNA815_14632} Mlig455_022920 {REF} {Length: 1424} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=65.4]; Ankyrin repeats (3 copies) [PF12796.9, score=61.1]; Ankyrin repeats (many copies) [PF13857.8, score=57.9]; Ankyrin repeat [PF13606.8, score=50.1]; Ankyrin repeat [PF00023.32, score=49.7]} {Human: ENSG00000173273, TNKS, tankyrase, [Score=56.2, Expect=9e-08]; ENSG00000236759, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000238134, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000285372, AC270292.3, tankyrase, [Score=55.5, Expect=2e-07]; ENSG00000232045, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000206376, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000227333, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000204371, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000224143, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=54.3, Expect=3e-07]; ENSG00000029534, ANK1, ankyrin 1, [Score=53.5, Expect=8e-07]} {Mouse: ENSMUSG00000096265, 4930467E23Rik, RIKEN cDNA 4930467E23 gene, [Score=56.6, Expect=3e-08]; ENSMUSG00000074449, Gm15319, predicted gene 15319, [Score=56.6, Expect=3e-08]; ENSMUSG00000095294, Gm21119, predicted gene, 21119, [Score=56.2, Expect=3e-08]; ENSMUSG00000031529, Tnks, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase, [Score=56.2, Expect=6e-08]; ENSMUSG00000013787, Ehmt2, euchromatic histone lysine N-methyltransferase 2, [Score=55.1, Expect=2e-07]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=55.1, Expect=2e-07]; ENSMUSG00000110591, Gm31371, predicted gene, 31371, [Score=54.3, Expect=8e-08]; ENSMUSG00000107280, Gm9495, predicted gene 9495, [Score=53.9, Expect=2e-07]; ENSMUSG00000106824, Gm7697, predicted gene 7697, [Score=53.9, Expect=2e-07]} {Dmel: FBgn0040752, Prosap, [Score=58.5, Expect=1e-08]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=51.6, Expect=9e-07]} {Smed: dd_Smed_v6_2072_0_20, dd_Smed_v6_2072_0_20, [Score=59.3, Expect=3e-09]} {RNA1509_39040} {RNA1310_19494} {RNA815_14632} |
85. | MligTC455_45496 | 144 | 2.99 | Mlig455_010048 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.720/0.00332 |
CAV2 | 2.657 | - | - | 0.928 | - | 0.738 | 0.991 | Mlig455_010048 {REF} {Length: 2607} {Pfam: Caveolin [PF01146.19, score=125.0]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=85.5, Expect=3e-21]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=89.4, Expect=7e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=79.0, Expect=2e-18]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [RH, Score=153, Expect=1e-48]} {RNA1509_20287} {RNA1310_50581.1, RNA1509_20287} {RNA1509_20287, RNA815_31873} |
86. | MligTC455_23621 | 323 | 6.72 | Mlig455_039694, Mlig455_039749 | Neo: - Age: - Region-enriched R2: 2.235/0.02499 |
2.656 | - | - | 0.859 | - | 0.803 | 0.994 | Mlig455_039694 {REF} {Length: 2054} {RNA1509_29694} {RNA1310_14789} {RNA815_12997} Mlig455_039749 {REF} {Length: 1751} {RNA1509_29694} {RNA1310_14789, RNA1509_29694} {RNA1509_29694, RNA815_12997} |
|
87. | MligTC455_46869 | 20 | 0.41 | Mlig455_054214 | Neo: - Age: - |
2.655 | - | - | 0.732 | - | 0.926 | 0.997 | Mlig455_054214 {REF} {Length: 1474} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=19.0]} {RNA1310_23944} {RNA815_32018} | |
88. | MligTC455_50643 | 38 | 0.8 | Mlig455_007952, Mlig455_008053 | Neo: - Age: - |
VSX1 | 2.648 | - | - | 0.907 | - | 0.770 | 0.971 | Mlig455_007952 {REF} {Length: 1358} {Pfam: Homeodomain [PF00046.31, score=79.6]} {Human: ENSG00000100987, VSX1, visual system homeobox 1, [RH, Score=197, Expect=4e-60]; ENSG00000119614, VSX2, visual system homeobox 2, [RH, Score=196, Expect=2e-59]} {Mouse: ENSMUSG00000021239, Vsx2, visual system homeobox 2, [RH, Score=196, Expect=6e-60]; ENSMUSG00000033080, Vsx1, visual system homeobox 1, [RH, Score=195, Expect=2e-59]} {Dmel: FBgn0263512, Vsx2, Visual system homeobox 2, [RH, Score=204, Expect=3e-60]} {Celegans: WBGene00000435, ceh-10, Homeobox protein ceh-10, [RH, Score=204, Expect=2e-63]} {Smed: dd_Smed_v6_19286_0_1, dd_Smed_v6_19286_0_1, [RH, Score=211, Expect=2e-66]} {RNA1310_76393} {RNA815_51313} Mlig455_008053 {REF} {Length: 2271} {RNA1310_76393} {RNA815_51313} |
89. | MligTC455_49490 | 48 | 1 | Mlig455_054769 | Neo: - Age: - |
2.646 | - | - | 0.985 | - | 0.897 | 0.764 | Mlig455_054769 {REF} {Length: 1663} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
90. | MligTC455_23640 | 29 | 0.6 | Mlig455_067288 | Neo: - Age: - |
2.645 | - | - | 0.814 | - | 0.872 | 0.959 | Mlig455_067288 {REF} {Length: 820} {RNA1310_58177} {RNA815_30723} | |
91. | MligTC455_30852 | 46 | 0.96 | Mlig455_019345, Mlig455_019563, Mlig455_059135 | Neo: - Age: - |
GRIA2, GRIK2, GRIK4 | 2.636 | - | - | 0.948 | - | 0.713 | 0.975 | Mlig455_019345 {REF} {Length: 3399} {Pfam: Ligand-gated ion channel [PF00060.28, score=95.4]; Receptor family ligand binding region [PF01094.30, score=56.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=25.8]; Iron-containing alcohol dehydrogenase [PF13685.8, score=21.9]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=159, Expect=1e-39]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=157, Expect=9e-39]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=159, Expect=7e-40]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=155, Expect=2e-38]} {Dmel: FBgn0039927, CG11155, [Score=160, Expect=3e-40]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [RH, Score=281, Expect=4e-87]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} Mlig455_019563 {REF} {Length: 2692} {Pfam: Ligand-gated ion channel [PF00060.28, score=91.5]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=98.6, Expect=6e-23]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=95.9, Expect=5e-22]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=94.7, Expect=1e-21]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=96.7, Expect=2e-22]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=95.9, Expect=3e-22]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=94.7, Expect=9e-22]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=92.8, Expect=4e-21]} {Dmel: FBgn0038837, CG3822, [Score=99.4, Expect=2e-23]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=92.8, Expect=2e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=176, Expect=4e-53]} {RNA1310_21734.1} {RNA815_52393} Mlig455_059135 {REF} {Length: 3434} {Pfam: Receptor family ligand binding region [PF01094.30, score=58.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=45.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=23.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=71.6, Expect=2e-12]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=70.5, Expect=3e-12]} {Dmel: FBgn0038837, CG3822, [Score=62.0, Expect=1e-09]} {Celegans: WBGene00001617, glr-6, GLutamate Receptor family (AMPA), [Score=68.6, Expect=6e-12]} {Smed: dd_Smed_v6_41723_0_2, dd_Smed_v6_41723_0_2, [Score=85.1, Expect=8e-18]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} |
92. | MligTC455_43324 | 71 | 1.47 | Mlig455_041984 | Neo: - Age: - Region-enriched R2: 6.623/0.00573 |
2.633 | - | - | 0.771 | - | 0.899 | 0.963 | Mlig455_041984 {REF} {Length: 388} {NoTransDecoderORF} {RNA1509_49821} {RNA1310_52560.2} {RNA815_59873} | |
93. | MligTC455_46823 | 69 | 1.44 | Mlig455_040455, Mlig455_042847 | Neo: - Age: - Region-enriched R2: 5.281/0.02950 |
ANGPTL2 | 2.629 | - | - | 0.867 | - | 0.811 | 0.951 | Mlig455_040455 {REF} {Length: 1444} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=152.3]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=129, Expect=8e-34]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=129, Expect=9e-34]; ENSG00000085265, FCN1, ficolin 1, [Score=128, Expect=1e-34]; ENSG00000160339, FCN2, ficolin 2, [Score=125, Expect=1e-33]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=132, Expect=4e-35]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=129, Expect=6e-34]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=127, Expect=3e-33]} {Dmel: FBgn0033312, CG8642, [Score=117, Expect=4e-30]} {Celegans: WBGene00017013, ensh-1, [Score=55.1, Expect=2e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=111, Expect=2e-27]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} Mlig455_042847 {REF} {Length: 1175} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=154.0]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=132, Expect=7e-35]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=132, Expect=1e-34]; ENSG00000085265, FCN1, ficolin 1, [Score=130, Expect=2e-35]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=126, Expect=1e-32]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=136, Expect=2e-36]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=132, Expect=5e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=130, Expect=1e-34]} {Dmel: FBgn0033312, CG8642, [Score=117, Expect=4e-30]} {Celegans: WBGene00017013, ensh-1, [Score=57.4, Expect=3e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=114, Expect=2e-28]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} |
94. | MligTC455_17678 | 121 | 2.53 | Mlig455_036741 | Neo: - Age: - Region-enriched R2: 3.030/0.00234 Regeneration-downregulated R4: -3.160 Regeneration-depleted R4: -3.160 |
TNNC2 | 2.625 | - | - | 0.889 | - | 0.963 | 0.773 | Mlig455_036741 {REF} {Length: 924} {Pfam: EF-hand domain pair [PF13499.8, score=100.6]; EF-hand domain [PF13405.8, score=75.3]; EF hand [PF00036.34, score=73.4]; EF-hand domain pair [PF13833.8, score=55.4]; EF hand [PF13202.8, score=44.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=23.7]; EF-hand domain [PF14658.8, score=20.3]} {Human: ENSG00000101470, TNNC2, troponin C2, fast skeletal type, [Score=74.7, Expect=4e-17]} {Mouse: ENSMUSG00000017300, Tnnc2, troponin C2, fast, [Score=74.7, Expect=3e-17]} {Dmel: FBgn0040351, CG11638, [Score=68.6, Expect=5e-14]} {Celegans: WBGene00000286, cal-2, CALmodulin related genes; Calmodulin-like protein, [Score=72.0, Expect=3e-16]} {Smed: dd_Smed_v6_4669_0_1, dd_Smed_v6_4669_0_1, [Score=68.2, Expect=4e-15]} {RNA1310_42119} {RNA815_21011} |
95. | MligTC455_16952 | 79 | 1.65 | Mlig455_001182 | Neo: - Age: - |
2.621 | - | - | 0.969 | - | 0.706 | 0.946 | Mlig455_001182 {REF} {Length: 3873} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [RH, Score=67.0, Expect=3e-14]} {RNA1509_4618} {RNA1310_46281} {RNA815_28578} | |
96. | MligTC455_32452 | 209 | 4.35 | Mlig455_029642 | Neo: - Age: - |
PKD1L2 | 2.618 | - | - | 0.764 | - | 0.856 | 0.998 | Mlig455_029642 {REF} {Length: 12740} {Pfam: Polycystin cation channel [PF08016.14, score=219.7]; REJ domain [PF02010.17, score=146.9]; PKD domain [PF00801.22, score=43.1]; PLAT/LH2 domain [PF01477.25, score=39.5]; Ion transport protein [PF00520.33, score=33.9]; PKD domain [PF18911.2, score=26.0]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=137, Expect=4e-31]; ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=136, Expect=4e-31]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=131, Expect=1e-29]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=191, Expect=1e-47]; ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [Score=182, Expect=5e-45]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=184, Expect=8e-46]} {Smed: dd_Smed_v6_15525_0_1, dd_Smed_v6_15525_0_1, [Score=281, Expect=4e-75]} {RNA1509_5774} {RNA1310_70.1} {RNA815_41} |
97. | MligTC455_42376 | 61 | 1.27 | Mlig455_069890 | Neo: - Age: - |
2.61 | - | - | 0.956 | - | 0.728 | 0.926 | Mlig455_069890 {REF} {Length: 630} {TRANSSPLICED} {Pfam: PAN domain [PF00024.28, score=26.1]} {RNA1509_53783} {RNA1310_37190} {RNA815_24434} | |
98. | MligTC455_47975 | 31 | 0.64 | Mlig455_018682, Mlig455_043427 | Neo: - Age: Up-Down-Down |
ISL1 | 2.607 | - | - | 0.961 | - | 0.712 | 0.934 | Mlig455_018682 {REF} {Length: 3387} {Pfam: LIM domain [PF00412.24, score=95.5]; Homeodomain [PF00046.31, score=55.3]; Homeobox KN domain [PF05920.13, score=23.7]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [Score=202, Expect=6e-60]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [Score=202, Expect=4e-60]} {Dmel: FBgn0003896, tup, tailup, [RH, Score=178, Expect=3e-49]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [RH, Score=228, Expect=5e-69]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=320, Expect=1e-103]} {RNA1310_20628} {RNA815_37694} Mlig455_043427 {REF} {Length: 3365} {Pfam: LIM domain [PF00412.24, score=77.4]; Homeodomain [PF00046.31, score=53.3]; Homeobox KN domain [PF05920.13, score=21.8]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [Score=167, Expect=2e-46]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [Score=167, Expect=1e-46]; ENSMUSG00000032318, Isl2, insulin related protein 2 (islet 2), [Score=160, Expect=4e-44]} {Dmel: FBgn0003896, tup, tailup, [Score=144, Expect=1e-37]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [Score=204, Expect=6e-60]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=274, Expect=7e-86]} {RNA1310_20628} {RNA815_37694} |
99. | MligTC455_41338 | 68 | 1.41 | Mlig455_007838 | Neo: - Age: Up-Up-Down |
2.605 | - | - | 0.982 | - | 0.749 | 0.874 | Mlig455_007838 {REF} {Length: 4757} {RNA1310_34392} {RNA815_25763} | |
100. | MligTC455_52393 | 60 | 1.25 | Mlig455_039640 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.560 Region-enriched R2: 5.399/0.01138 |
CHAT | 2.6 | - | - | 0.988 | - | 0.737 | 0.875 | Mlig455_039640 {REF} {Length: 3681} {TRANSSPLICED} {Pfam: Choline/Carnitine o-acyltransferase [PF00755.22, score=546.9]} {Human: ENSG00000070748, CHAT, choline O-acetyltransferase, [RH, Score=520, Expect=1e-176]} {Mouse: ENSMUSG00000021919, Chat, choline acetyltransferase, [RH, Score=521, Expect=3e-177]} {Dmel: FBgn0000303, ChAT, Choline acetyltransferase, [Score=452, Expect=1e-149]} {Celegans: WBGene00000481, cha-1, Choline O-acetyltransferase, [RH, Score=356, Expect=1e-113]} {Smed: dd_Smed_v6_6208_0_1, dd_Smed_v6_6208_0_1, [Score=535, Expect=0.0]} {RNA1509_40088} {RNA1310_20833} {RNA815_26395} |